{{knowledge objective
|Identifiant=OIC-187-07-A
|Item_parent=Hypersensitivity and mucocutaneous allergies in children and adults. Urticaria, atopic and contact dermatitis
|Item_parent_short=Hypersensitivity and mucocutaneous allergies in children and adults. Urticaria, atopic and contact dermatitis
|Rank=A
|Title=Knowing how to treat acute urticaria
|Description=None
|Rubric=Management
|Contributors=
|Order=7}}
- '''Etiological treatment'''

Avoidance of favouring/triggering factors

- '''Symptomatic treatment'''

2<sup>th</sup> generation anti-H1 antihistamines 1 to 2 tablets/day.

In the event of chronic acute urticaria and/or poor response; 2nd<sup>th</sup> generation anti H1 antihistamines may be increased to 4 tsp/day.


In the event of associated signs of anaphylaxis, treatment should be guided by the symptoms presented;

Ø Parenteral adrenaline in cases of anaphylactic shock or asphyxiant angioedema,

Ø Oxygen therapy if desaturation,

Ø vascular filling if anaphylactic shock,

Ø administration of inhaled beta-2 mimetics in the event of bronchospasm.